Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.095059v1, 2007; 10.1373/clinchem.2007.095059
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.095059v1
54/1/154    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kabagambe, E. K
Right arrow Articles by Arnett, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kabagambe, E. K
Right arrow Articles by Arnett, D. K.

Received on July 17, 2007
Accepted on October 19, 2007

Article

Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study

Edmond K Kabagambe 1*, Michael Y. Tsai 2, Paul N. Hopkins 3, Jose M. Ordovas 4, James M. Peacock 5, Ingrid B. Borecki 6, Donna K. Arnett 1

1 Department of Epidemiology, University of Alabama at Birmingham, School of Public Health, Birmingham, AL
2 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
3 Department of Internal Medicine, University of Utah, Salt Lake City, UT
4 JM-USDA-HNRCA, Tufts University, Boston, MA
5 Division of Epidemiology and Community Health, University of Minnesota, School of Public Health, Minneapolis, MN
6 Division of Statistical Genomics, Department of Genetics, Washington University, School of Medicine, St. Louis, MO

* To whom correspondence should be addressed. E-mail: edmondk{at}uab.edu.

BACKGROUND: Different fatty acids may vary in their effect on the metabolic syndrome (MetS). We tested whether fatty acid classes measured in erythrocytes are associated with the MetS or its components.

METHODS: Included were men [n = 497; mean (SD) age, 49 (16) years] and women [n = 539; age, 48 (16) years] from 187 families in a National Heart, Lung, and Blood Institute (NHLBI) family study of the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) conducted in Utah and Minnesota. We used gas chromatography to measure erythrocyte fatty acids and obtained data on potential confounding variables from interviewer-administered questionnaires.

RESULTS: The prevalence of the MetS as defined by the updated Adult Treatment Panel III criteria was 36.8% in Utah and 39.6% in Minnesota (P >0.05). In a multivariate model that included 4 fatty acid classes, covariates, and pedigree as a random effect, the odds ratios (95% confidence interval) for the MetS in the 1st, 2nd, 3rd, and 4th quartile of polyunsaturated fatty acids were 1.00, 0.72 (0.47–1.10), 0.67 (0.43–1.05), and 0.39 (0.24–0.64), respectively (P for trend = 0.0002). For the corresponding quartiles of saturated fatty acids, the odds ratios were 1.00, 1.19 (0.77–1.84), 1.48 (0.94–2.34), and 1.63 (1.01–2.63), respectively (P for trend = 0.03). Unlike n6 fatty acids, which showed an inverse association (P <0.05) with MetS, n3, trans, and monounsaturated fatty acids were not associated with the MetS (P >0.05). We observed significant correlations (P <0.05) between fatty acid classes, insulin, and components of the MetS.

CONCLUSIONS: Polyunsaturated fats are inversely associated with the MetS, whereas saturated fatty acids are positively associated with the MetS, probably through their effect on lipids, adiposity, insulin, and blood pressure.




The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Clin. Nutr.Home page
C. M Phillips, L. Goumidi, S. Bertrais, J. F Ferguson, M. R Field, E. D Kelly, G. M Peloso, L A. Cupples, J. Shen, J. M Ordovas, et al.
Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome
Am. J. Clinical Nutrition, December 1, 2009; 90(6): 1665 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Garaulet, Y.-C. Lee, J. Shen, L. D Parnell, D. K Arnett, M. Y Tsai, C.-Q. Lai, and J. M Ordovas
CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids
Am. J. Clinical Nutrition, December 1, 2009; 90(6): 1466 - 1475.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Phillips, L. Goumidi, S. Bertrais, M. R. Field, G. M. Peloso, J. Shen, R. McManus, S. Hercberg, D. Lairon, R. Planells, et al.
Dietary Saturated Fat Modulates the Association between STAT3 Polymorphisms and Abdominal Obesity in Adults
J. Nutr., November 1, 2009; 139(11): 2011 - 2017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.